Autoplaque vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

EchoGo Pro

by Ultromics

AI Verdict

Autoplaque and EchoGo Pro are adjacent tools, both leveraging AI to enhance cardiac diagnosis but utilizing different imaging modalities. Autoplaque is designed for quantitative analysis of coronary plaques and stenoses from CT angiography images, aiding in heart attack risk prediction. In contrast, EchoGo Pro automates stress echocardiography analysis to diagnose coronary artery disease, providing near-instant reports from echo data.

Choose Autoplaque if…

Choose Autoplaque if your primary need is a detailed, quantitative analysis of coronary plaques and luminal stenoses directly from CT angiography images. This workstation-based software is ideal for clinicians requiring precise measurements and characterization of atherosclerotic plaque to aid in heart attack risk prediction and treatment guidance.

View Autoplaque →

Choose EchoGo Pro if…

Choose EchoGo Pro if you require an AI-powered, cloud-based solution for automated stress echocardiography analysis to rapidly diagnose coronary artery disease. This tool is best suited for practices seeking near-instant, accurate reports and seamless integration with existing workflows without the need for local software installation.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	EchoGo Pro
Pricing	Unknown	Contact vendor for pricing
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	Cloud-based (SaaS)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro (Tool B) is a cloud-based SaaS solution, which generally offers superior usability due to no software installation requirements and minimal training. Autoplaque (Tool A), being workstation-based, may require more setup and ongoing maintenance.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in cardiology. Autoplaque aids in heart attack risk prediction through quantitative CT angiography plaque analysis, while EchoGo Pro automates stress echocardiography analysis for coronary artery disease diagnosis. They address different diagnostic modalities and aspects of cardiac care, making a direct comparison of 'more' clinical value challenging.

Pricing & Value

EchoGo Pro

While both tools require direct vendor contact for pricing, EchoGo Pro (Tool B) explicitly mentions available reimbursement codes (e.g., CPT 0932T, NTAP XXE2X19) for related EchoGo products. This transparency regarding potential reimbursement pathways suggests a clearer path to financial value for healthcare providers compared to Autoplaque (Tool A), which provides no pricing or reimbursement details.

Enterprise Readiness

EchoGo Pro

EchoGo Pro (Tool B) demonstrates stronger enterprise readiness with its cloud-based (SaaS) deployment, explicit HIPAA compliance, and BAA availability. It also highlights vendor-neutral PACS compatibility and seamless integration with existing clinical workflows (DICOM, HL7). Autoplaque (Tool A) is workstation-based and lacks explicit statements on BAA or HIPAA compliance in the provided information, which are critical for enterprise adoption.

Innovation

Tie

Both tools represent significant innovation in healthcare AI. Autoplaque (Tool A) offers AI-powered quantitative analysis of coronary plaques from CT angiography for heart attack risk prediction. EchoGo Pro (Tool B) provides AI-powered automated stress echocardiography analysis for CAD diagnosis, delivered as a cloud solution. Each brings advanced AI capabilities to different diagnostic challenges in cardiology.

Support & Docs

Tie

Neither the provided structured facts nor web searches yielded explicit details on dedicated support channels or comprehensive documentation for either Autoplaque (Tool A) or EchoGo Pro (Tool B). While EchoGo Pro's SaaS model implies less need for traditional software installation support, concrete information to compare support offerings is absent for both.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	EchoGo Pro
Name	Autoplaque	EchoGo Pro
Company	Cedars-Sinai Medical Center: AIM	Ultromics
Primary Imaging Modality	CT angiography images	Echocardiography
Key Analysis Focus	Quantitative analysis of coronary plaques and luminal stenoses	Automated stress echocardiography analysis for coronary artery disease

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and EchoGo Pro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities do these AI tools analyze?

Autoplaque is designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography (CTA) images. In contrast, EchoGo Pro automates the analysis of stress echocardiography to assist in diagnosing coronary artery disease.

What specific cardiac conditions do these AI tools help diagnose or assess?

Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque and measurement of luminal stenoses from CTA images, aiding in heart attack risk prediction and treatment guidance. EchoGo Pro automates stress echocardiography analysis to improve the diagnosis of coronary artery disease (CAD), including heart failure with preserved ejection fraction (HFpEF).

What are the key differences in the analytical output provided by each tool?

Autoplaque offers automated vessel, plaque, and lumen segmentation, allowing for review and editing by clinicians, and provides measurements of vessel diameter and area. EchoGo Pro delivers near-instant, comprehensive reports from automated echocardiogram analysis, focusing on the identification of coronary artery disease.

Is there information available regarding reimbursement for using these tools?

For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings. For Autoplaque, pricing is not disclosed, and no specific reimbursement information is provided in the given facts, though AI-enabled coronary plaque analysis from CCTA has Category I CPT codes like 75577 effective January 1, 2026.